Known targets — ChEMBL curated mechanism
GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ
The experimentally established mechanism targets of Secobarbital. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRB3 known ✓ | P28472 | 1/20 | 0.67 |
| ▸ | GABRA2 known ✓ | P47869 | 1/20 | 0.67 |
| ▸ | GABRB2 known ✓ | P47870 | 1/20 | 0.67 |
| ▸ | MMP9 | P14780 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.67 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Secobarbital SCHEMBL8085730 | 1.00 | MMP9 (1.00) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL80735 | 1.00 | MMP9 (1.00) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL80734 | 1.00 | MMP9 (1.00) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL7599361 | 0.98 | MMP9 (0.97) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL41182 | 0.98 | MMP9 (0.97) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL614906 | 0.98 | MMP9 (0.97) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL28198576 | 0.97 | MMP9 (0.94) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Secobarbital SCHEMBL7778384 | 0.91 | MMP9 (0.83) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Thiamylal SCHEMBL1666144 | 0.89 | MMP9 (0.79) | MMP9CYP3A4KDM4EALDH1A1GABRB3 | |
| Thiamylal SCHEMBL548050 | 0.89 | MMP9 (0.79) | MMP9CYP3A4KDM4EALDH1A1GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2839 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250271426-A1 | REDUCTION OF BITTER TASTE OF ACTIVE PHARMACEUTICAL INGREDIENTS AND RELATED ASSAYS AND SCREENING METHODS | FIRMENICH INCORPORATED (US) | 2025-08-28 | — | — | US | claimed |
| EP-4493928-A1 | REDUCTION OF BITTER TASTE OF ACTIVE PHARMACEUTICAL INGREDIENTS AND RELATED ASSAYS AND SCREENING METHODS | Firmenich Incorporated (US) | 2025-01-22 | — | — | EP | claimed |
| US-12161695-B2 | GABA A receptor agonists for treatment of disorders influenced by dysfunction BETA cells | DIAMYD MEDICAL AB (SE) | 2024-12-10 | — | — | US | claimed |
| US-20240122859-A1 | EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION | NOKHA TRADING LLP (IN) | 2024-04-18 | — | — | US | claimed |
| US-20230381195-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY (TBI) AND RELATED DISORDERS | MEHRA AKHIL (US) | 2023-11-30 | — | — | US | claimed |
| WO-2023205647-A1 | REDUCTION OF BITTER TASTE OF ACTIVE PHARMACEUTICAL INGREDIENTS AND RELATED ASSAYS AND SCREENING METHODS | FIRMENICH INCORPORATED (US) | 2023-10-26 | — | — | WO | claimed |
| CN-116179496-A | Hybridoma cell strain secreting anti-phenobarbital drug monoclonal multi-residue antibody and application thereof | 江南大学 | 2023-05-30 | — | — | CN | claimed |
| WO-2022172225-A1 | EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION | LYRUS LIFE SCIENCES PVT. LTD. (IN) | 2022-08-18 | — | — | WO | claimed |
| US-20210228488-A1 | EXTENDED RELEASE COMPOSITIONS AND PROCESS FOR PREPARATION | RUBICON RES PRIVATE LIMITED (IN) | 2021-07-29 | — | — | US | claimed |
| US-20210113586-A1 | NEW USE AND METHODS OF MODULATING IMMUNE RESPONSES | DIAMYD MEDICAL AB (SE) | 2021-04-22 | — | — | US | claimed |
| WO-2000001805-A1 | CELLS AND ANIMALS DEFICIENT IN PROTEIN KINASE C EPSILON | MESSING ROBERT O (US) | 2000-01-13 | — | — | WO | claimed |
| EP-0935523-A4 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | GEN MILLS INC (US) | 1999-12-29 | — | — | EP | claimed |
| EP-0935523-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | GENERAL MILLS, INC. (US) | 1999-08-18 | — | — | EP | claimed |
| WO-1998051282-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-19 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| US-5770222-A | Therapeutic drug delivery systems | IMARX PHARMACEUTICAL CORP. (US) | 1998-06-23 | — | — | US | claimed |
| WO-1998018610-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | LENGERICH BERNHARD H VAN (US) | 1998-05-07 | — | — | WO | claimed |
| US-4466953-A | Polymeric diffusion matrix | KEY PHARMACEUTICALS, INC. (US) | 1984-08-21 | — | — | US | claimed |
| US-4175119-A | Composition and method to prevent accidental and intentional overdosage with psychoactive drugs | PORTER GARRY L | 1979-11-20 | — | — | US | claimed |
| US-3989823-A | COMBATING SMOKING | COSTANZO FRANCOIS DI | 1976-11-02 | — | — | US | claimed |